-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
-
Summary
-
Reviva Pharmaceuticals Holdings, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q4 2020 to Q3 2024.
- Reviva Pharmaceuticals Holdings, Inc. Preferred Stock, Shares Authorized for the quarter ending September 30, 2024 was 10M shares.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)